Scarica l'app Stockscreener
10.35
3.40%
0.34
Dopo l'orario di chiusura:
10.35
Immatics N V Borsa (IMTX) Ultime notizie
(IMTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
IMTX Technical Analysis & Stock Price Forecast - Intellectia AI
Is Immatics (IMTX) Building a PRAME-Focused Platform or Stretching Its Oncology Ambitions Too Thin? - Sahm
Aug Technicals: Should I invest in Immatics NV Equity Warrant before earnings2026 PostEarnings & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Retail Trends: Should you buy the dip on Immatics NV2026 Decliners & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Reactions: What is the target price for Immatics NV stock2026 Movers & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Immatics NV (IMTX) seeing strong enrollment in a key phase 3 trial of drug candidate - MSN
Earnings Miss: Is Immatics NV a cyclical or defensive stock2026 Price Swings & Real-Time Volume Spike Alerts - baoquankhu1.vn
IMTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Earnings Recap: Will Immatics NV Equity Warrant benefit from government policyWeekly Gains Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Bear Alert: Is Immatics NV stock risky to hold now2026 Technicals & Stepwise Swing Trade Plans - baoquankhu1.vn
Immatics N.V. Ordinary Shares (IMTX) Stock Price Today & Analysis - Gotrade
Aug Closing: Does Immatics NV stock have upside surprise potentialTrade Exit Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Panic Selling: How is Immatics NV Equity Warrant managing supply chain issues2026 Setups & Daily Profit Focused Stock Screening - baoquankhu1.vn
Aug Closing: What is Immatics NV Equity Warrants market position2026 Breakouts & Breakdowns & Long Hold Capital Preservation Tips - baoquankhu1.vn
Breakouts Watch: Is Immatics NV forming a breakout pattern2026 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Immatics price target raised to $17 from $14 at BofA - MSN
(IMTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Immatics N.V. (NASDAQ:IMTX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com
Immatics NV stock advances on promising TCR-T cell therapy data amid biotech rally - AD HOC NEWS
Fund Flows: Will Immatics NV Equity Warrant outperform its industry peers2026 Buyback Activity & Risk Controlled Swing Alerts - baoquankhu1.vn
IMTX SEC FilingsImmatics N.V 10-K, 10-Q, 8-K Forms - Stock Titan
Here Is What You Need To Know Before Investing In Immatics N.V. (IMTX) - MSN
IMTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Immatics (IMTX) Expected to Announce Earnings on Thursday - MarketBeat
Immatics (IMTX) Chief Development Officer files Form 3 detailing equity - Stock Titan
Immatics (IMTX) CMO Cedrik Britten reports option, RSU and share holdings - Stock Titan
Immatics (IMTX) General Counsel reports stock options and RSUs - Stock Titan
[Form 3] Immatics N.V. Initial Statemen... - Stock Titan
Immatics (IMTX) CEO reports options, RSUs and share holdings - Stock Titan
Immatics (IMTX) director reports sizeable stock option holdings - Stock Titan
Immatics (IMTX) CFO reports 350,000 stock options holding - Stock Titan
Immatics N.V. (IMTX) director Eliot Forster details stock option holdings - Stock Titan
Immatics (IMTX) Chief People Officer reports 211,000 share options on Form 3 - Stock Titan
Immatics (IMTX) director discloses existing stock option grants - Stock Titan
Immatics (IMTX) director discloses multiple long-dated stock options - Stock Titan
Immatics (IMTX) director reports multiple long-dated stock option grants - Stock Titan
Immatics (IMTX) COO details stock options, RSUs and share holdings - Stock Titan
Immatics (IMTX) CBO details stock option and RSU positions - Stock Titan
Immatics (IMTX) director Chambre details ordinary share and option stakes - Stock Titan
Immatics (IMTX) director Michael G. Atieh reports stock option positions - Stock Titan
Immatics (IMTX) Chief Innovation Officer discloses option and RSU stakes - Stock Titan
Why Immatics (IMTX) Is Down 6.4% After Deepening Losses And Highlighting SUPRAME Phase 3 Progress - simplywall.st
Immatics (IMTX) director entities disclose indirect share and option stakes - Stock Titan
Aug PreEarnings: What is the target price for Immatics NV stockWeekly Trading Summary & Verified Technical Signals - baoquankhu1.vn
Risk Check: Is Immatics NV a defensive stock2026 Winners & Losers & Reliable Momentum Entry Alerts - baoquankhu1.vn
Immatics NV Stock (ISIN: NL0015255052) Advances on Promising TCR-T Therapy Data Amid Biotech Sector - AD HOC NEWS
Immatics N.V. (IMTX) director Hothum discloses options and indirect shares - Stock Titan
IMTX: Jefferies Analyst Biren Amin Rates Immatics with a "Buy" and Sets Price Target at $18.00 | IMTX Stock News - GuruFocus
Immatics (NASDAQ:IMTX) Stock Price Up 9.3%Here's What Happened - MarketBeat
Immatics (NASDAQ:IMTX) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
Immatics Phase 3 Progress Sharpens View On Anzu Cel Launch Upside - Yahoo Finance
Immatics N.V. $IMTX Shares Purchased by Baker BROS. Advisors LP - MarketBeat
Immatics NV Stock (ISIN: NL0015255052) Holds Steady Amid Biotech Sector Volatility - AD HOC NEWS
(IMTX) Risk Channels and Responsive Allocation - Stock Traders Daily
Immatics N.V. (IMTX) Seeing Strong Enrollment in a Key Phase 3 Trial of Drug Candidate - Insider Monkey
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):